当前位置：药药网 / 数据中心 /奥大利亚药品评审报告(本栏目收费,不能显示细节,电话13136136841)
药品名称：
活性成份：
发布日期：-
奥大利亚药品评审报告745个记录(本栏目收费,不能显示细节,电话13136136841)
奥大利亚药品评审报告
161
Prolastin?-C
Alpha-1-proteinase inhibitor (human)
2016/10/14
162
Aczone
Dapsone
2017/12/1
163
Blincyto
Blinatumomab (rch)
2018/2/5
164
Fluzone High-Dose
Inactivated high-dose trivalent influenza vaccine
2018/7/9
165
Simponi
Golimumab
2009/12/14
166
Coveram
Perindopril arginine / Amlodipine (as besylate)
2009/11/13
167
Zeldox IM
Ziprasidone mesilate
2009/12/18
168
Pergoveris
Follitropin alfa (rch) / Lutropin alfa (rch)
2010/1/11
169
Azarga
Brinzolamide / Timolol Maleate
2010/2/19
170
MabThera
Rituximab
2010/2/19
171
Cimzia
Certolizumab pegol
2009/12/22
172
Beriplex P/N
Human Prothrombin Complex
2010/1/15
173
Berinert
Human C1 esterase inhibitor
2010/1/14
174
Erbitux
Cetuximab
2010/1/15
175
Zavesca
Miglustat
2010/3/9
176
Genotropin
Somatropin
2010/3/9
177
Rasilez HCT / Enviage HCT
Aliskiren (as hemifumarate) / Hydrochlorothiazide
2010/3/12
178
Cayston
Aztreonam
2010/2/2
179
Avastin
Bevacizumab
2009/12/14
180
Seroquel, Seroquel XR
Quetiapine (as fumarate)
2010/4/13